It is a pharma private limited company based in Sanand, Gujarat, India, established in 2003.
2003 | Sanand, Gujarat, India | ActiveLeo Formulations Private Limited, a active private limited company, was established on 09 July 2003 in Sanand, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231GJ2003PTC042590. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Employing 6 professional, Its leadership includes Devam Arvindbhai Mody (Director), Anita Arvind Mody (Director), Arvind Shantilal Mody (Director). It holds ₹2.00 Cr open charges and ₹2.70 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. - 7, Gujarat Pharma Techno Park, Village Sari, Taluka Sanand, Post Bavla, Sanand, Gujarat, 382220.
U24231GJ2003PTC042590
042590
09 July 2003
₹1.50 M
₹1.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Leo Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devam Arvindbhai Mody | Director | 09 Jul 2003 | Current |
| Anita Arvind Mody | Director | 01 Dec 2004 | Current |
| Arvind Shantilal Mody | Director | 09 Jul 2003 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Leo Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 60.62% increase. The company also saw a substantial improvement in profitability, with a 46.64% increase in profit. The company's net worth Soared by an impressive increase of 61.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Leo Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹27,035,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2020 | Others | ₹2.00 Cr | Open |
| 27 Jun 2018 | Others | ₹1.50 Cr | Satisfied |
| 11 Oct 2012 | Siddhi Co. Op. Bank Ltd | ₹2.10 M | Satisfied |
| 27 Feb 2012 | Bank Of Baroda | ₹8.30 M | Satisfied |
| 22 Jan 2010 | Bank Of Baroda | ₹1.64 M | Satisfied |
Explore comprehensive loan charge details -
Leo Formulations has a workforce of 6 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Leo Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leo Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Leo Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Leo Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
Progress on A charge with Others of Rs. 20.00 M registered on 26 Jun 2020 with Charge ID 100344759 was modified on 30 Oct 2021. was documented.
The activity A charge with Others amounted to Rs. 20.00 M with Charge ID 100344759 was registered on 26 Jun 2020. was completed.
Progress on A charge registered on 27 Jun 2018 via Charge ID 100191674 with Others was fully satisfied on 19 Apr 2020. was documented.
Progress on A charge with Others of Rs. 15.00 M registered on 27 Jun 2018 with Charge ID 100191674 was modified on 12 Jul 2018. was documented.
The CIN of Leo Formulations Private Limited is U24231GJ2003PTC042590.
Leo Formulations Private Limited is headquartered at Plot No. - 7, Gujarat Pharma Techno Park, Village Sari, Taluka Sanand, Post Bavla, Sanand, Gujarat, 382220.
Leo Formulations Private Limited was incorporated on 09 July 2003.
The current directors of Leo Formulations Private Limited are
The primary industry of Leo Formulations Private Limited is Trade.
Leo Formulations Private Limited is unlisted.
The authorized capital of Leo Formulations Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of Leo Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX